The Molecular Biology of Myeloma

David S. Siegel, MD, PhD

Video Categories: Targeted Therapies

Dr. David S. Siegel discusses the importance of understanding the molecular biology of myeloma. Physicians can now look at and offer alternative treatments to patients that they identify will most likely do poorly with traditional treatment. He believes this area will develop quickly over the next 2 to 5 years.

September 20, 2013

Developing an Accurate Price Model for Personalized Medicines

Randy Vogenberg discusses the complexities of developing pricing for personalized medicine products

January 20, 2016

Targeting Resistant Cells

Dr Wainberg and Dr Gerson talk about going after this cell population and some of the findings of myeloid leukemia research.